How Long for Mounjaro Side Effects to Start (and What to Expect)

The first few days: what's actually happening and when symptoms tend to appear

Tirzepatide (the active ingredient in Mounjaro) is a dual GIP and GLP-1 receptor agonist. Part of how it works is by slowing gastric emptying (food moves through your stomach more gradually) which is useful for appetite control but can also produce that familiar unsettled feeling in the gut. According to the NHS medicines page for tirzepatide, the most common side effects are nausea, vomiting, diarrhoea, constipation, and indigestion. If you want to know how long after taking Mounjaro side effects tend to start, the short answer is that they typically surface within the first 24 to 72 hours after each new injection, particularly after the very first pen.

The starting dose of 2.5mg exists primarily to let your body adapt. Its role is adjustment, not yet the full therapeutic effect, so some of the early discomfort is simply the system recalibrating. Symptoms that appear in this window are usually mild to moderate. Most people find they settle considerably by the end of the first two weeks, and often sooner.

That said, some people notice nothing at all in the early days. Individual response to tirzepatide is genuinely variable: gut sensitivity, eating habits, hydration, and the pace of titration all play a role. If you are curious about how quickly side effects tend to appear for different people, that variation is covered in more detail separately.

What changes after each dose increase (the pattern that repeats

A question our prescribers hear most weeks goes something like: "I felt fine on 5mg, but now I've moved up to 7.5mg and the nausea is back) is that normal?" It is. Each step up the dose ladder can temporarily reintroduce mild GI symptoms, because the body is essentially adapting again to a higher level of the medicine. The timing mirrors the initial experience: symptoms tend to arrive within a day or two of the new dose and usually settle within the same one-to-two-week window.

This repeat pattern is worth knowing about before it happens. If you understand it going in, you are far less likely to interpret a brief bout of nausea after a dose change as a sign that something has gone wrong. Practical steps that can help during these windows include eating smaller meals, staying well hydrated, avoiding very fatty or rich food around the time of the injection, and not lying down immediately after eating.

The full side-effect profile of Mounjaro covers both the common GI symptoms and the less frequent ones in more detail. For a broader picture of tirzepatide and how it works, our Mounjaro treatment page is a good starting point.

Symptoms that are unusual and when to get medical help

The vast majority of side effects with Mounjaro are temporary and manageable. But some symptoms need prompt medical attention, and it is important to know the difference before you start treatment.

In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis as an infrequent but potentially serious side effect. The warning sign is severe, persistent pain in the abdomen that may radiate into the back, sometimes accompanied by vomiting. This is not the same as ordinary nausea or mild stomach discomfort. If you experience it, stop the injection and seek urgent medical help rather than waiting to see if it settles.

Other symptoms that warrant medical contact rather than watchful waiting include: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, a widespread rash), symptoms of gallbladder problems (sudden pain in the upper right abdomen, fever, or jaundice), and severe or prolonged vomiting or diarrhoea that leads to dehydration. Changes in vision should also be flagged to a doctor promptly.

If you are uncertain whether a symptom is serious, the default is to contact your prescriber or NHS 111. You can report suspected side effects at any point via the MHRA Yellow Card scheme, this helps regulators monitor medicines in real-world use. And if you have specific questions about your own situation, our support team is available seven days a week.

Making the call: how to weigh this information against starting treatment

The side-effect picture for Mounjaro is worth reading clearly, without either minimising it or letting it become disproportionately alarming. Most people on tirzepatide experience some degree of GI discomfort early on; most find it manageable and temporary. Clinical trial data from the SURMOUNT programme (which involved thousands of adults across multiple studies) showed that side effects were the most common reason for discontinuation, but that the majority of participants completed the full course. The NICE technology appraisal of tirzepatide (TA1026) considered this evidence in full when recommending the medicine.

The practical decision for many people is not whether side effects exist, but whether they are prepared for the pattern and know what to watch for. That is exactly what the consultation process is designed to address. At nume, a real clinician reads your answers the same day (not software) and side effects are part of that conversation, not a footnote. If you want to understand more about the timing of side effects before committing to treatment, that page goes further on the early-week experience. For those further along and wondering about specific symptoms, what sulphur burps indicate is something we cover separately. The free consultation with our prescribers is the right place to discuss your personal health picture before starting.